| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.1M | +46.9% |
| Cost of Revenue | $9.6M | +45.8% |
| R&D Expense | $76.4M | +29.1% |
| SG&A Expense | $30.2M | +82.7% |
| Operating Income | -$105.4M | — |
| Interest Expense | $6.9M | -17.4% |
| Pre-tax Income | -$112.5M | -42.2% |
| Income Tax | $2.9M | +533.6% |
| Net Income | -$115.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -57.3% |
| Current Assets | $17.7M | +5210.5% |
| Total Assets | $38.3M | -71.3% |
| Current Liabilities | $37.5M | — |
| Total Liabilities | $73.5M | — |
| Stockholders' Equity | -$35.2M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.0M | — |
| Capital Expenditures | $1.3M | +109.0% |
| Investing Cash Flow | -$1.3M | +99.0% |
| Financing Cash Flow | $82.0M | -38.9% |
| Free Cash Flow | -$95.3M | -6255.0% |
| — |
| EPS (Basic) | -$0.73 | +38.1% |
| EPS (Diluted) | -$0.73 | +38.1% |